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reproduction in any medium, provided the original author and source are credited.SUMMARYTransplantation of the retinal pigment epithelium (RPE) is being developed as a cell-replacement therapy for age-related macular degen-
eration. Human embryonic stem cell (hESC) and induced pluripotent stem cell (iPSC)-derived RPE are currently translating toward clinic.
We introduce the adult human RPE stem cell (hRPESC) as an alternative RPE source. Polarized monolayers of adult hRPESC-derived RPE
grown on polyester (PET) membranes had near-native characteristics. Trephined pieces of RPE monolayers on PET were transplanted
subretinally in the rabbit, a large-eyed animal model. After 4 days, retinal edema was observed above the implant, detected by spectral
domain optical coherence tomography (SD-OCT) and fundoscopy. At 1 week, retinal atrophy overlying the fetal or adult transplant
was observed, remaining stable thereafter. Histology obtained 4 weeks after implantation confirmed a continuous polarized human
RPE monolayer on PET. Taken together, the xeno-RPE survived with retained characteristics in the subretinal space. These experiments
support that adult hRPESC-derived RPE are a potential source for transplantation therapies.INTRODUCTION
The retinal pigment epithelium (RPE) is a cellular mono-
layer between the retina and the underlying choroidal
vasculature. The RPE participates actively in the visual
process, notably by supporting the diurnal replenishment
of the photoreceptors (Strauss, 2005). RPE dysfunction
significantly contributes to the pathophysiology of age-
related macular degeneration (AMD), a leading cause of
blindness (Lim et al., 2012). There are currently no
disease-altering therapies available for the vast majority
(over 85%) of AMD patients that suffer from the dry
form of the disease, which is characterized by extra-
cellular deposits termed drusen beneath the RPE and sub-
sequent RPE atrophy in the macula. The remaining
approximately 15% of patients have wet AMD, in which
neovascularization invades from the choroid; for these
patients, repeated intravitreal injections with antiangio-
genic drugs offer a highly effective, albeit palliative, treat-
ment (Singer et al., 2012). Replacement of dysfunctional
submacular RPE with a cell-based therapeutic agent repre-
sents a potentially curative treatment strategy (Binder
et al., 2007). Some previous attempts in patients have
been shown to improve vision, but most were limited
by immune reactions, surgical complications, late-stage
disease, or lack of an adequate RPE cell source (Stanzel
and Holz, 2012). Translocation of an autologous patch64 Stem Cell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authorof RPE/choroid remains clinically the most popular
approach, because some patients benefit from the proce-
dure, despite its high complication rates (van Zeeburg
et al., 2012).
With the development of RPE differentiation protocols
from human embryonic stem cells (hESCs) and induced
pluripotent stem cells (iPSCs) (Hirami et al., 2009; Kliman-
skaya et al., 2004), RPE transplantation has experienced a
powerful renaissance, as scientists and clinicians envision
an unlimited supply of RPE for transplantation. However,
much is still not understood with regard to the physi-
ology of stem-cell-derived RPE (Liao et al., 2010) and
transplantation into patients is in the early stages. Pilot
data from a phase I/II trial (NCT01226628 and
NCT01344993) with a suspension of hESC-derived RPE
injected in patients with dry AMD or Stargardt’s disease
suggest a favorable safety profile and some limited
improvement in vision (Schwartz et al., 2012); further
dose-escalation in this multicenter study is on-going.
This is encouraging, given that prior studies using RPE
cell suspensions showed they failed to survive or function
on aged submacular Bruch’s membrane (Sugino et al.,
2011) and are more likely to be rejected than are RPE
monolayers (Diniz et al., 2013).
A cultured human RPEmonolayer that exhibits the phys-
iology of its native counterpart could be a valuable alterna-
tive to an RPE-cell suspension. This type of culture has beens
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Survival of Subretinal hRPE Xenografts in Rabbitsreadily attained using fetal- or pluripotent-stem-cell-
derived RPE. However, establishing such cultures from
adult RPE has proven difficult and inconsistent, due to its
propensity to undergo epithelial-mesenchymal transition
(reviewed in Burke, 2008). We have optimized culture con-
ditions that robustly activate a subpopulation of adult
human RPE stem cells (RPESC), expand, and then differen-
tiate them into highly pure RPE monolayers that exhibit
physiological features of native RPE (Blenkinsop et al.,
2013; Salero et al., 2012). This protocol allows us to explore
the potential of adult RPESC-derived RPE for cell-replace-
ment therapy. To date, we do not know which cell source
will turn out to be therapeutically successful, and therefore,
testing all potential candidates is important. Using a cell
source derived from the adult human RPE may possess
several potential advantages, such as fewer ethical con-
cerns compared to hESC and fetal human RPE (hRPE),
the possibility of routine histocompatibility leukocyte
antigen matching or even autologous transplantation
(using a patient’s own remaining healthy RPESCs) to mini-
mize immunosuppression, reduced proliferative potential
than hESCs or human iPSCs and therefore reduced tumor-
igenesis risk, and reduced threat of generating abnormal
cell types.
RPE monolayers grown on cell carriers would facilitate
surgical handling and long-term functionality by substitut-
ing some or all of the functions of the aged Bruch’s
membrane (Binder et al., 2007). Coimplantation of differ-
entiated RPE monolayers on a substrate has been attemp-
ted in animal models only in a few instances and with
limited success (Bhatt et al., 1994; Diniz et al., 2013; Nico-
lini et al., 2000). Improvements would involve employing a
biocompatible matrix that exhibits minimal deformation
after transplantation, longer-term assessment postsurgery,
and use of a large-eyed animal model for better assessment
of surgical technique.
We have previously reported on a method and instru-
mentation to deliver ultrathin rigid-elastic cell carriers
(polyester [PET]) into the subretinal space (SRS) of rabbits
(Stanzel et al., 2012). Here, we demonstrate this technology
can be used to delivermonolayers of humanRPE on perme-
able polyester carriers into the SRS of the rabbit. Notably,
we find RPE isolated from adult cadaver donors can expand
20-fold and survive as a polarized RPE monolayer
for 1 month after transplantation, therefore representing
a clinically relevant RPE cell source. Transplants were
followed with state-of-the-art ophthalmic imaging tech-
nology, including spectral domain optical coherence
tomography (SD-OCT), confocal scanning-laser ophthal-
moscopy (cSLO), color funduscopic photography, and his-
tology. In addition, the influence of local and systemic
immunosuppression on retinal tissue alterations following
xenografting was evaluated.StemRESULTS
Preparation and Characterization of the RPE-Carrier
Monolayers
Adult human RPESC (hRPESC)-derived RPE and fetal hRPE
monolayers were compared for their growth characteristics
on the carrier PET material. Fetal hRPE cells seeded at 2 3
105 cells/cm2 on PET inserts formed uniform, hexagonal
monolayers by 2 weeks postconfluence, which repig-
mented by 6–8 weeks (Figure 1A). Cultures were used for
transplantation at 2 to 3 months postconfluence, when
transepithelial electrical resistance (TER) values ranged
from 737–1415 U*cm2, mean 1244 ± 161 U*cm2 (n = 60),
and 514–776 U*cm2, mean 657 ± 60 U*cm2 (n = 60), from
two different donor cultures (Figure 1C). Fetal RPE cultured
in this manner shows morphology and gene/protein
expression similar to native RPE, thereby serving as a refer-
ence for adult-stem-cell-derived RPE (Liao et al., 2010).
About 5 3 106 adult hRPEs were typically isolated per
donor. During the first month, the cultures went through
2–4 population doublings, thus expanding to approxi-
mately 2.5 3 107. We then seeded adult hRPE onto PET
inserts at 13 105 cells/cm2 until they formed uniform, hex-
agonal monolayers 4 weeks postconfluence, expanding
another 2–4 more times during this passage. As a result,
after 3 months, the adult RPESCs and their progeny had
expanded 20-fold, and from one donor, we obtained
approximately 1 3 108 RPEs (Figure 1B).
We monitored adult hRPE characteristics during the cul-
ture period by measuring TER, gene expression, and polar-
ized protein localization immunohistochemically. After
2 months on the PET substrate, when the adult hRPE
monolayers exhibited a uniform, polygonal shape, TER
was measured regularly to confirm development of tight
junctions (Figure 1 and Figure S1 available online) and
were found to range between 210–339 U*cm2 at 8 weeks
after plating, with a mean of 308 ± 18.7 U*cm2 (n = 12)
andmean 240 ± 24.9 U*cm2 (n = 12) from respective donor
cultures.
Gene-expression profiling was conducted using RNA
extracted from adult hRPE tissue at the time of dissection
(referred to as native) versus RNA extracted from adult
hRPE after 2 months on PET (Figure 1E; n = 5 donors).
Cultured adult hRPE exhibited largely similar but some-
times higher expression of RPE markers compared to the
native tissue.
To determine purity and polarization of the adult hRPE
cultures, we performed immunostaining using character-
istic RPEmarkers, assessed by confocal imaging (Figure 1F).
Claudin-19 was present along the apical-lateral membrane
along with the tight-junction complex protein ZO-1, indi-
cating the existence of a functional epithelial barrier (Peng
et al., 2011). Ezrin, a membrane-associated proteinCell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authors 65
Figure 1. Fetal and Adult Human RPE Cultured over 2 Months Exhibit Similarities to Native RPE
(A and B) Cultured (A) fetal and (B) adult hRPE display hexagonal morphology and varied pigmentation. The scale bars represent 50 mm.
(C and D) TER measurements of fetal and adult hRPE, respectively.
(E) mRNA expression of typical RPE transcripts was compared to its genetically matched native RPE counterpart from five adult hRPE
donors, including those used for transplantation. The asterisk denotes P value > 0.01/paired t test. The error bars represent SEM.
(F) Adult hRPE cultures display expression of markers typical of native RPE in their polarized localization. DAPI is cyan, whereas all other
immunofluorescence is gold. Claudin 19, ezrin, ZO1, and MCT1 are preferentially located on the apical side. RPE65 and CRALBP are
cytoplasmic. The scale bars represent 10 mm.
See also Figure S1.
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Table 1. All Surgical Conditions Listed According to Implant
Type, Surgical Protocol, and Use of Local and/or Systemic
Immunosuppression
Implantation
Protocol
Surgical Protocola Rabbits
Used
Donors
UsedGelatin Plasmin TCA DXP
RD only (19)b no no no no 7
no no yes no 4
no yes yes no 1
no no yes yes 7
PET alone (7) yes yes yes no 2
yes yes no no 1
no no no no 4
fhRPE (40) yes yes no no 2 2c
yes yes yes no 5
yes no yes no 6
no no yes no 6
no yes yes no 3
yes no no no 4
no no yes yes 14
ahRPE (5) no no yes no 5 2c
Yes/no indicates variable(s) included in particular implantation protocol.
TCA refers to triamcinolone acetonide, DXP is dexamethasone phosphate,
RD means (bleb) retinal detachment, PET is the polyester terephthalate
cell carrier, fhRPE is fetal human retinal pigment epithelium, and ahRPE
is adult human retinal pigment epithelium.
aSurgeons: B.V.S. = 47, N.E. = 10, S.S. = 3.
bThere were eight rabbits treated with RD only; 11 blebs created next
to another implantation side.
cCultures derived from a single donor were used for a particular
implantation.
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tially in RPE microvilli (Bonilha et al., 1999). The visual
cycle proteins cellular retinaldehyde-binding protein
(CRALBP) and RPE65 (Bunt-Milam and Saari, 1983;
Redmond et al., 1998) were localized in the cytoplasm, as
expected. Monocarboxylate transporter 1 (MCT1) was
present apically (Philp et al., 1998).
The appropriate localization of these proteins, combined
with the gene-expression pattern and TER measurements,
were similar to native RPE, demonstrating appropriate
physiology of the adult hRPE monolayers to be used for
transplantation.
Cultured hRPE Xenografted into Rabbit SRS
hRPE cultures grown on PETmembranes were trephined to
generate bullet-shaped implants approximately 1.1 mm 3Stem2.2 mm (6–8000 cells), as described previously (Stanzel
et al., 2012). Subretinal implantation of 45 such constructs
was evaluated, which included 40 fetal and five adult
human RPE monolayer implants (Table 1). The RPE
monolayer transplant was placed cell-carrier down on
intact host RPE within the SRS (Figures 2 and 3; Movie
S1). In addition, controls with bleb retinal detachments
alone (bRD) (n = 19) and PET carrier-only implants (n = 7)
were performed to differentiate surgical trauma from
biological effects (Figure S2; Movie S2).
On first postoperative exam (days 3–5), a white retinal
opacity overlying the hRPE implant was seen on fundus
photography, along with occasional triamcinolone crystals
trapped around the retinotomy site. The whitish opacity
was subsequently lost in both hRPE implant types, with
all remaining follow-up exams (beyond 1 week postopera-
tion [post-OP]) showing a steep edge around the implant
periphery (Figure 2A for fetal and 2C for adult; Movies S3
and S4).
On the first SD-OCT follow-up (at 3–5 days post-OP), the
neural retina above the fetal and adult hRPE implant
showed an increased overall thickness, with loss of typical
retinal reflectance layering, as well as slowed clearance of
subretinal fluid from the bRD (Figure 2, B1 and D1, respec-
tively). Xenografted adult hRPE on PET followed similar,
albeit slightly delayed, patterns as seen with the fetal trans-
plants. Notably, however, the retina was typically adherent
to both hRPE implant variants on the apical surface, and
the implant plus carrier appeared apposed to the host
RPE layer on the basal surface. The choroidal vascular layer
underneath both hRPE implant types appeared to have less
reflectivity and slightly increased volume compared to
adjacent regions on SD-OCT at all time points. After
1week, an apparent retinal tissue loss over the implant cen-
ter was discernible on SD-OCT (Figure 2). The findings were
well correlated with color fundus photography. Following
the initial retinal thinning seen after the first week, the
retina remained stable for the duration of the follow-up
examinations (Figure 2; Movies S3 and S4).
On infrared cSLO, a distinct reflectivity halo appeared to
surround the PETalone aswell as the hRPE implants, which
correlated with a loss of outer retinal SD-OCT bands (Fig-
ure 2A). The halo diameter was smaller than the original
size of the bRD. PET-only implants produced a smaller
halo than hRPE xenografts.
We asked whether encapsulating the graft in additional
materials would help the surgical delivery and potentially
reduce the retinal thinning. Temporary graft encapsulation
with thermosensitive gelatin and/or plasmin-assisted
vitrectomy, however, was found to cause more aggressive
retinal destruction and choroidal engorgement on SD-
OCT compared to unaided implantation of fetal hRPE/
PET implants (Figure S2). In contrast, we found that allCell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authors 67
Figure 2. Representative Case of Fetal and hRPE Transplantation into Immune Competent-Rabbit SRS with In Vivo and
Histomorphological Comparison
(A and C) Funduscopy images of subretinal RPE + PET implant at respective time points, (A1–A3 and C1) infrared cSLO images, (C2 and C3)
color fundus photograph, (A4 and C4) postmortem eye-cup macroscopic photograph. (B and D) Longitudinal section through center of
RPE + PET implant center at indicated time points, (B1–B3 and D1–D3) SD-OCT images, and (B4 and D4) paraffin and resin histologic
section, respectively. Scale bars in columns A–D and rows 1–3 are 200 mm and, in row 4, 250 mm.
See also Figure S2 and S3 and Movies S1, S2, S3, and S4.
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intravitreal triamcinolone (TCA) injection at the end of
the surgery. This long-acting synthetic corticosteroid is
routinely given intraocularly to reduce immune responses.
Ophthalmic and systemic complications related to the
implantation procedure are summarized in Table 2.
Characterization of hRPE Xenografts by
Immunolabeling and Transmission Electron
Microscopy
Animals were sacrificed and perfusion-fixed at 4 weeks
posttransplantation and the recovered grafts then
sectioned. Microscopic inspection revealed that the grafts
had been maintained as a largely intact and continuous
cell monolayer. A positive pan-cytokeratin (pCK) signal,
an established RPE marker, was confirmed for fetal and
adult hRPE monolayers (Figures 3A and 3C). Additional
pCK reactivity was seen ‘‘underneath’’ the cell carrier, likely
from host RPE. Moreover, fetal and adult hRPE on PET
carriers stained positively for the human-specific marker
SC121, confirming survival of human RPE for 1 month as
a monolayer (Figure 3). Costaining of SC121 with an anti-
body to MCT1 and Ezrin, both apical membrane markers,68 Stem Cell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authorfurther confirmed that the RPE were (still) polarized (Fig-
ure 3). SC121+ RPE transplants were negative for the
expression of the cell-cycle marker ki67, the proliferation
marker phosphohistone H3, and for the apoptotic marker
caspase-3 (Figures 3F–3H), indicating absence of prolifera-
tion and apoptosis. We estimated the total human RPE
cell survival to be approximately 95% after 1 month by
using the SC121 positivity; we measured the total length
of the carrier and the length of SC121 stain and calculated
the percent coverage of SC121 over the total carrier length.
On transmission electron micrography (TEM), polarized
RPE cells were observed on the PET carriers from both fetal
and adult transplants (Figures 3I and 3J). These results
confirm survival of polarized human RPE from fetal and
adult donors xenografted into rabbit SRS over 4 weeks.
Effect of Systemic Immunosuppression on Fetal RPE
Transplant and Retinal Integrity
We conducted a consecutive series of transplants with
preoperative, systemically immunosuppressed animals,
aiming to improve preservation of the neural retina above
the fetal RPE monolayer xenograft. Systemic dexa-
methasone (DXP) immunosuppression (2.5–3 mg/kg/days
Stem Cell Reports
Survival of Subretinal hRPE Xenografts in Rabbitsintramuscularly) in 14 rabbits resulted in inconsistent
maintenance of the inner retinal layers (3 of 14),
yet always leading to an atrophy of the outer photoreceptor
cell layer above the hRPE implant (Figure 4; Movie S5). The
surviving RPE cells appeared pleiomorphic and scattered
into patches on the PET carrier. By contrast, animals that
did not receive systemic immunosuppression, but were
treated with TCA injection, had a complete disarray and/
or absence of all retinal layers above the implant, but the
hRPE monolayer was much better preserved.
Remarkably, on SD-OCT, near-normal choroidal reflec-
tivity patterns were seen underneath the fetal hRPE
implant as early as 1 week postimplantation in most (9 of
14) DXP-suppressed animals (Figure 4G), similar to areas
with normal retina or PET carrier-only implants. Nonim-
munosuppressed rabbits showed a distinctly diminished
reflectivity and locally increased volume within the
choroid underneath the fetal hRPE grafts, with no apparent
histomorphologic correlate at 4 weeks postimplantation
for these choroidal changes on SD-OCT. Perhaps mediated
through suppression of all peripheral blood leukocytes
(Jeklova et al., 2008), systemic DXP seemed to effectively
dampen choroidal immune reactions underneath fetal
hRPE grafts. See Table 2 for DXP-related complications.
In summary, systemic immunosuppression with DXP
resulted in poor survival of fetal hRPE transplants,
whereas local administration of TCA intravitreally im-
proved surgical outcome.DISCUSSION
The advances in hESC, iPSC, and RPESC technology have
opened new opportunities to test whether transplantation
of RPE into the SRS of patients with RPE-related diseases
might restore some of the lost RPE function, ultimately
leading to preservation or restoration of vision. One major
unknown is whether these RPE cells can survive as a
monolayer in the SRS and maintain their identity. Here,
we demonstrate that polarized human fetal and adult RPE
monolayers cultured on a polyester matrix can survive
grafting into the rabbit SRS, thus resolving many of the
current roadblocks concerning clinical RPE monolayer
transplantation.
RPESCs isolated from elderly donor eyes were expanded
and successfully differentiated to generate approximately
1 3 108 RPE per donor. Considering 5 3 104 or fewer RPE
cells are required to cover the macula, using adult hRPE
from one donor has the potential to treat many hundreds
of patients. While promising, the expansion potential of
adult hRPE is limited and the generation of multiple banks
would be required to enable treatment of the millions of
patients suffering from eye diseases such as AMD. OneStempotential alternative to adult hRPE thought to have an
unlimited expansion potential is hESC- and iPSC-derived
RPE. However, a recent study shows changes in the physi-
ology of iPSC-RPE after serial passaging (Singh et al.,
2013); therefore, the difference between these lines and
adult hRPE with regard to their expansion capabilities
may not be significant.
The adult RPESC-derived RPE cultures were shipped live
from the US to the German surgical team. Despite
the transportation stress, the cultures soon exhibited
morphology and TER values comparable to preshipment
levels. Successful shipment of cultured implants between
clinical-grade cell production to distant surgical sites
should therefore be possible, hinting at the potential rapid
spread of therapy adoption. Very little is known regarding
optimal conditions for RPE implant shipment, and our
studies have established conditions for successful cultured
RPE monolayer transport.
Here, we show that, similar to fetal hRPE (Liao et al.,
2010), adult hRPE cultures can exhibit characteristics
similar to native adult human RPE. Cultured adult hRPE
had TER measurements that were actually closer to native
adult RPE than cultured fetal hRPE. These two RPE culture
systems were developed independently in separate labora-
tories and as such used slightly different culture methods.
More detailed comparison is warranted between human
native fetal and adult tissues and RPE cultures made from
these cells in order to determine the optimal cells for a
particular target patient population.
After implantation into the rabbit eye, both fetal and
adult RPE grown on a biocompatible, permeable polyester
matrix survived and maintained key properties. Moreover,
we observed no occurrence of scarring on the retinal
surface (due to proliferative vitreoretinopathy) or graft pro-
liferation. The fact that both fetal and adult hRPE behaved
similarly suggests these two distinct RPE populations share
comparable features with regard to transplantation.
We tested whether gelatin and plasmin could facilitate
implant placement in the SRS but found survival of the
RPE cells adversely affected. Gelatin and plasmin have
been reported to be proinflammatory (Huang et al., 1998;
Lai, 2009; Verstraeten et al., 1993), which may explain
the reduced and patchy RPE coverage on PET carriers we
observed in these cases at 4 weeks postimplantation (data
not shown).
Remarkably, fetal and adult hRPE monolayers survived
without systemic immunosuppression, which agrees with
a previous fetal hRPE carrier transplant study (Bhatt et al.,
1994). Our study now extends these findings to adult
hRPE. Importantly, we demonstrate that adult hRPESC-
derived RPE monolayers maintained cell-polarity markers
up to 4 weeks postgrafting. A significant body of evidence
now suggests that the RPE actively modulates the immuneCell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authors 69
(legend on next page)
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Table 2. List of Complications Following the Implantation Procedure
Complications
Implant Type
RD Only PET Alone ahRPE fhRPE
Without DXP Without DXP Without DXP Without DXP With DXP
Ophthalmic
Postoperative endophthalmitis no no no no no
Corneal epithelial defectsa no no 2/5 no 14/14
Retinal detachments, entry 3/60
Posterior subcapsular cataracts (traumatic) Several casesa
Persistent subretinal fluid no no no 2/40
Systemic
Reduction in muscle mass no no no no 14/14
Slow-healing skin abrasions at hind paws no no no no 3/14
Anesthetic complicationsb no no no no 2/14
Death rate 9/46 3/14
DXP is dexamethasone phosphate, RD means (bleb) retinal detachment, PET is the polyester terephthalate cell carrier, fhRPE is fetal human retinal pigment
epithelium, and ahRPE is adult human retinal pigment epithelium.
aThese cases still allowed for SD-OCT and fundus imaging.
bMalignant hypertension, tachypnea, and hyperthermia during recovery from anesthesia.
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has qualities of an immune-privileged tissue (Sugita, 2009).
Like other epithelial cells, RPEs in single-cell suspension
lose their polarized cytoskeletal and membrane-protein
distribution, likely becoming more susceptible to immune
rejection. Consistent with this, single-cell suspensions of
RPE do not survive when transplanted underneath the
kidney capsule, whereas intact RPE sheets do (Wenkel
and Streilein, 2000). Suspensions of human fetal RPE trans-
planted into the rabbit SRS showed cellular infiltration
with subsequent destruction (Gabrielian et al., 1999). InFigure 3. Xenografted Polarized Human RPEs Survive Subretinally
One month after hRPE transplantation, implant sites were screened f
(A) Fetal hRPE stained for pan-cytokeratin (scale bar, 50 mm); inset s
200 mm).
(B) Fetal hRPE stained for SC121 (red) and MCT1 (green; scale bars, 1
(C) Adult hRPE stained for pan-cytokeratin (scale bar = 50 mm); inset
200 mm).
(D–H) Adult hRPE stained for SC121 (red). (D) Adult hRPE stained for
transplanted into rabbit SRS show absence of expression of ki67 (F), p
hRPE cells were found in TEM (I and J). Nuclei with regular chromatin w
arrowhead) had formed between the xenograft and PET carrier (blac
abutting to the atrophic neural retina (NR), and junctional structures
arrowhead) were discerned apically. Mitochondria (MC) were seen in th
in (J) is a histologic processing artifact. Left images in (I) and (J) take
in left at 25,0003; scale bars represent 2 mm/inset 0.2 mm distance
Stemcontrast, unsupported, cultured patches of fetal human
RPE transplanted into albino rabbits seemed to survive
1 month, after which they showed signs of rejection
(Sheng et al., 1995). Hence, it appears that maintaining
RPE intercellular connectivity, i.e., as monolayers, is bene-
ficial to prevent rejection. We therefore speculate that sur-
vival of these fetal and adult RPE xenografts in rabbits is
promoted by their maintenance as a polarized monolayer.
It is possible that xenograft survival in our model was
also facilitated due to implant placement above an intact
host RPE, because the SRS itself has also been consideredfor at Least 1 Month
or human-specific and RPE markers.
hows section overview stained with hematoxylin/eosin (scale bar,
25 mm and 25 mm [inset]).
shows section overview stained with hematoxylin/eosin (scale bar,
MCT1 (green). (E) Human adult RPE stained for ezrin (green). hRPEs
hosphohistone H3 (G), and caspase-3 (H). Polarized fetal and adult
ere found in the basal compartment, a basal lamina ([I], large black
k asterisks). Melanosomes (M) in multiple stages, some microvilli
with desmosomes (small black arrowhead) and tight junctions (red
e basolateral part of the cell. Detachment from cell carrier (asterisk)
n at 10,5003magnification; right micrographs are rectangular zone
in (I) and (J).
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Figure 4. Effect of Systemic Immunosuppression on Fetal hRPE Transplant and Retinal Integrity
(A–J) Immunosuppression was induced preoperatively in 14 animals with DXP. Controls and DXP-treated animals received an intravitreal
injection of 1 to 2 mg TCA given at the end of the procedure. Animals were imaged at day 28 post-OP with cSLO infrared reflectance imaging
(A and F), SD-OCT (B and G), and processed for histology (C–E and H–J) on the same day. Notice the rather continuous fetal hRPE layer on
PET carriers without systemic DXP immunosuppression (C–E), whereas pigmented cells on DXP-suppressed samples appear mottled and
discontinuous (H–J). By contrast, preservation of inner retinal reflectance layers on SD-OCT was possible in 3 of 11 survivors with DXP
suppression. Red arrows in (C)–(E) and (H)–(J) point to putative hRPE transplant; black arrow (E) and retinal detachment in (C)–(E) are
histologic processing artifacts. Scale bars, 200 mm (A, B, F, and G), 250 mm (C, E, and H), and 50 mm (J). See also Movie S5.
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of the RPE by sodium iodate abolishes such immune privi-
lege (Wenkel and Streilein, 1998). However, we note that,
in the study by Bhatt et al. (1994) in which fetal hRPE
cell monolayers survived 6 weeks, they removed the host
RPE prior to transplantation, indicating that graft survival
was not due to the host RPE layer creating an immune-
privileged SRS.
We found that systemic DXP immunosuppression was
less successful than local administration of TCA but view
the translational value of these findings cautiously. Little
is known about differences in immune rejection between
RPE xenografts, as done here, and allografts as contem-
plated in patients. To our knowledge, there have been no
direct comparisons of these two scenarios, and we note
that species and animal strain differences may also be rele-
vant. Attempts to compare the immune responses in the
SRS with other xenograft models may not be appropriate
because of the unique immunologic environment under-
neath the retina. In RPE allografts, major histocompatibil-
ity complex II expression by the RPE (and its subsequent
recognition by T cells; Zhang and Bok, 1998), along with
cytokine production (interleukin [IL]-6 and interferon g)72 Stem Cell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authorhave been implicated in rejection (Enzmann et al., 2000).
In contrast, RPE xenografts in rat or rabbit elicit macro-
phage infiltration and subsequent destruction (Carr et al.,
2009; Gabrielian et al., 1999). Cytokines (IL-1 and IL-6)
have also been implicated in such a reaction (Abe et al.,
1999). (Thymic) lymphocyte infiltration has not been
demonstrated in more than 20 published studies on RPE
xenografts, yet both cyclosporine and tacrolimus, which
are thought to suppress T-cell-mediated rejection, showed
some efficacy in delaying xenograft rejection in rabbits
(Lai et al., 2000;Wang et al., 2002). Cyclosporine has erratic
plasma levels (thus requiring frequent serum measure-
ments) and does not prevent allo- or xenograft rejection
of an RPE (suspension) in rats or rabbits (Carr et al., 2009;
Lai et al., 2000), thus questioning its usefulness. Tacrolimus
has similar mechanisms of action but greater likelihood of
toxic side effects. In an attempt to ameliorate negative
retinal changes, we chose to administer DXP, as it predict-
ably suppresses all peripheral leukocyte lineages in the
rabbit (Jeklova et al., 2008). The adverse effect of DXP
that we observed on xenograft survival was unexpected
but perhaps mediated through the RPE glucocorticoid
receptor, which promotes RPE proliferation (He et al.,s
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suppression protocol exists at present for hRPE xenograft
models, but our data indicate that intravitreal TCA allows
hRPE survival for at least 1 month, indicating that it could
be valuable for longer-term studies.
Carrier implantation into the SRS with or without hRPE
resulted in a degenerated retina immediately above the
implant. The cause is not clear andmight bemultifactorial.
Despite reports to the contrary (Szurman et al., 2006), we
believe that the bRD is unlikely to cause retinal degenera-
tion, because we found that producing a similar bleb
without subsequent insertion of a carrier results inminimal
damage to photoreceptors and negligible retinal degenera-
tion, a finding supported by others (Ivert et al., 2002). The
rabbit retina is merangiotic, meaning only part of the inner
retina is supplied by retinal vessels and is therefore more
dependent on the choriocapillaris for all metabolic needs
compared to holangiotic species that possess a retinal
vasculature that penetrates throughout the inner retina,
i.e., humans and rats. Because we placed a 10-mm-thick
device between the photoreceptors and the RPE, we disrup-
ted this normally intimidate intercellular relationship with
a barrier, which likely led secondarily to the observed outer
retinal degeneration. Similar observations have been made
using retinal chip implants, where impermeable variants of
the implants result in atrophy of photoreceptor cell layers
(Montezuma et al., 2006).
Porosity of cell carriers seems to play a crucial role in
maintaining neural retinal health and layering, as implan-
tation of an acellular PETcarrier with 3.0 mmdiameter pores
results in significantly better preservation of outer retinal
layers compared to a PETcarrier with smaller, 0.4 mmdiam-
eter pores (B.V.S., Z.L., R.B., and F.G.H., unpublished data).
However, other than a small study by Lu et al. (2012), car-
rier membranes with optimal porosity for retinal preserva-
tion and permissive to RPE culture were not systematically
evaluated to our knowledge. hRPE on PET carriers xeno-
grafted into the SRS resulted in initial retinal edema
followed by a dramatic atrophy of all overlying retinal
layers within 1 week. Such a pattern was clearly different
from carrier-only controls, where only the outer retinal
layers degenerated. RPE-transplant-induced retinal ‘‘melt-
ing’’ (Del Priore et al., 2001; Rezai et al., 2000) or photore-
ceptor destruction (Diniz et al., 2013; Zhang and Bok,
1998) has been observed by others and remains an un-
solved problem in RPE xenotransplantation (da Cruz
et al., 2007). Our work indicates that, rather than surgical
trauma, it is the configuration of the subretinal implants
themselves which cause the observed retinal degeneration.
Optimization of RPE cell carriers to better mimic physio-
logic Bruch’s membrane is an important subject and is
currently being explored by us and many others (Liu
et al., 2013; Hynes and Lavik, 2010; Kearns et al., 2012;StemSubrizi et al., 2012). Reducing such retinal degeneration
after subretinal hRPE engraftment in rabbit SRS will
improve the use of the rabbit as a cost-effective, large-
eyed animal model. Future work will focus on identifying
an appropriate cell carrier that more closely mimics the
precious relationship between the outer retinal layer and
the choriocapillaris.EXPERIMENTAL PROCEDURES
RPE Cultures
Fetal RPE
Permission to work with human RPE was obtained from the Ethics
Committee of the University of Bonn. Two pairs of fetal human
eyes at 19th and 20th week of gestation were obtained from
Advanced Bioscience Resources. The tissues were transported in
CO2-independent media (Invitrogen) supplemented with 5%
normal calf serum and 100 IU penicillin/100 mg streptomycin on
ice and were processed within 48 hr postenucleation. RPE cells
were isolated, expanded in low calcium media, and subsequently
differentiated on uncoated 10-mm-thick polyester Transwell (PET)
inserts (Corning Life Sciences catalog number 3470) according to
a prior protocol (Hu and Bok, 2001).
Adult RPE
The method for adult RPE culture followed our prior publication
(Blenkinsop et al., 2013). Briefly, cadaver donor globes within
36 hr postmortemwere dissected, the vitreous and retina removed,
and the posterior eye-cup rinsed with calcium- and magnesium-
free PBS, and then incubated in 1% dispase (2.4 IU/ml; Sigma-
Aldrich catalog number D4818) for 45 min at 37C. Sheets of
RPE were gently scraped off Bruch’s membrane and then layered
onto Dulbecco’s modified Eagle’s medium (DMEM)/F12 supple-
mented with 10% fetal bovine serum (FBS) and with 10% sucrose.
After 10 min, the lower fraction containing RPE sheets was
collected, centrifuged at 285 g for 5 min, resuspended in modified
DMEM/F12 (see Table S1) supplemented with 15% FBS, and plated
to cover roughly 50% of the well coated with placental extracel-
lular matrix (BD Biosciences). The culture medium was changed
every 2 to 3 days, with a gradual decrease in FBS from 15% down
to 2% by 2 weeks. RPE sheets attached and grew to confluence
within 2 weeks and were then passaged, plated into coated PET
inserts (described above), and cultured for another 2 months,
changing the medium two to three times weekly.Transepithelial Electrical Resistance Measurements
Followed standardized methods described in the Supplemental
Experimental Procedures.Quantitative PCR
Followed standardized methods described in the Supplemental
Experimental Procedures.Preparation of Implants
Adult hRPE cells isolated from two donors (72-year-old and
71-year-old females) cultured on PET inserts were shipped on wetCell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authors 73
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Rensselaer, NY to Bonn, Germany within 24 hr. The cultures
were left to recover in the incubator at 37C, 5% CO2 for 1 week
until transplantation. The TER values immediately prior to implan-
tation were around 220 and 315 U*cm2 for the respective donor
cultures.
Acellular and RPE-seeded implants were trephined from above
PET membranes using a custom-made, bullet-shaped trephine, as
described previously (Stanzel et al., 2012). RPE on the cut carriers
were rinsed three times with calcium- and magnesium-containing
Hank’s balanced salt solution (HBSS) immediately prior to implan-
tation. The implant dimensions were approximately 2.2 3
1.1 mm, accommodating approximately 6–8000 cells. Prior to
implantation, some membranes with and without cultured RPE
were encapsulated in sterile filtered 15% porcine gelatin, bloom
index 100 (Sigma-Aldrich catalog number G6144).
Rabbit Transplantation
Sixty female chinchilla bastard rabbits weighing 2–2.5 kg (Charles
River Laboratories) were utilized in experiments, which are
summarized in Table 1. All procedures were approved by the state
regulatory authorities of North Rhine-Westphalia (LANUV
84-02.04.2011.A130). Animals were kept in a specialized facility
with temperatures between 20 and 25C and exposure to regular
daylight, in standardized individual cages with free access to
food and water.
The surgical technique was further refined from our previously
published protocol (Stanzel et al., 2012; Movie S1). In brief, rabbits
were anesthetized by intramuscular injection of 65 mg/kg keta-
mine and 5 mg/kg xylazine and pupils dilated with 2.5% phenyl-
ephrine and 1% tropicamide eye drops. Eleven of 60 rabbits
received an intravitreal injection of 1 U homologous rabbit
plasmin in HBSS 1 hr prior to starting the procedure. Following
partial surgical removal of the vitreous (two-port core-vitrectomy),
a small bRD was gently raised with 25–30 ml HBSS via a 41G Teflon
cannula (DORC catalog number 1270.EXT) and Hamilton syringe,
thereby expanding the SRS for surgical maneuvers. Intraocular
pressure was set for 30 mmHg and was consistently associated
with a facile bRD induction, as compared to 20 or >50 mmHg.
The implant was then passed with the custom delivery instru-
ment from the vitreous cavity through an enlarged incision in
the retina into the SRS. RPE monolayer transplants were placed
cell-carrier-side down on intact host RPE, so that the xenografted
RPE faced the photoreceptors (Movie S1). Only the right eye was
used for experimentation, and one implant was placed per eye.
Immunosuppression
Local
Most rabbits received an intravitreal injection of 1 to 2 mg
preservative-free TCA at the end of the surgical procedure (see
Table 1). To control wound healing at the ocular surface, dexa-
methasone 1mg/g, neomycin sulfate 3,500 IU/g, polymyxin B sul-
fate 6,000 IU/g ointment (Isoptomax, Alcon Pharma) was applied
twice daily for 1 week postoperative onto the ocular surface.
Systemic
Immunosuppressionwas induced in 14 rabbits with intramuscular
injection of DXP (Dexa-ratiopharm, Ratiopharm) over 2 days,74 Stem Cell Reports j Vol. 2 j 64–77 j January 14, 2014 j ª2014 The Authorthree times/day, every 6 hr, 2.5–3 mg/kg, modified from a prior
study (Jeklova et al., 2008). On the day of surgery, the animals
were injected twice, 12 hr apart, with 2.5–3 mg/kg DXP, followed
by a once daily maintenance dose of 2.5–3 mg/kg DXP in the
morning until sacrifice. Animals were weighed regularly postim-
plantation and inspected by a veterinarian when necessary.
In Vivo Follow-Up
Rabbits had repetitive noninvasive retinal imaging performed at
post-OP days 4, 7, 14, and 28. Anesthesia and pupil dilation were
performed as described above. The cornea was frequently lubri-
cated with artificial tears (Optive, Allergan) to maintain its optical
clarity throughout imaging.
Spectral Domain Optical Coherence Tomography and Confocal
Scanning Laser Ophthalmoscopy
The Spectralis HRA/OCT device (Heidelberg Engineering) was used
to acquire laser-interferometric reflectance OCT images of the
retina and choroid, with resolutions comparable to a light micro-
scopic section. Longitudinal and transversal line OCT scans
through the center of the implant were taken with the 30-degrees-
of-visual-field setting of the Spectralis. Volume scans were
obtained with 60 mm distance between each scan with the device
set to 20 3 20 degrees of visual field centered on the implant. To
approximate human optical parameters to rabbit eyes, the Spec-
tralis’ corneal curvature settings were set by default to 4.2 mm.
Red-free and infrared cSLO images were taken at 30 degrees of
visual field in the HRA mode of the device.
Color Fundus Photographs
A Zeiss FF 450IR camera set to 30 degrees of visual field was used to
obtain color photographs to document funduscopic changes
around the implant site.
Histology
Perfusion Fixation and Sectioning
Rabbits were sacrificed 4 weeks after implantation in deep intra-
muscular anesthesia with an intracardial injection of T61. The
animals were desanguinated and then perfusion-fixed with 2%
glutaraldehyde (GA) or 4% formaldehyde (FA) both diluted in
0.1 M phosphate buffer. The enucleated eyes were then immer-
sion-fixed overnight in the same fixative. Anterior segments were
cut away with Vannas scissors and the eyecups photographed
under a binocular microscope (Zeiss OPMI 1) with a 5-megapixel
smartphone digital camera (iPhone 4, Apple). Full-thickness
samples (retina-sclera) of the implantation site were cut with a
surgical blade (Feather No. 22). GA probes were embedded in
Spurr’s resin (Sigma, EM0300-1KT) and 1 to 2 mmsemithin sections
cut and then stained with toluidine blue. FA-fixed materials
in paraffin were cut into 5 mm sections and stained with
hematoxylin/eosin or Mayer’s hematoxylin alone (if combined
with immunohistochemistry, see below). Light micrographs were
taken on an Olympus BX50 microscope equipped with a Nikon
DS-Vi1 digital camera.
Transmission Electron Microscopy
Ultrathin sections from both implant types (Spurr-embedded, see
above) were analyzed using a Philips CM 10 electron microscope
(Philips). Images were taken with Megaview3 CCD digital camera
and coupled with digital image software analysis (Olympus).s
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Transwell Membranes.
Transwell membranes were processed for immunocytochemistry
against Claudin-19 (1:100; R&D Systems), ZO-1 (1:100; Invi-
trogen), Ezrin (1:100; Cell Signaling Technology), MCT-1 (1:100;
Sigma), CRALBP (1:100; Abcam), RPE65 (1:100; a gift from
Dr. T. Michael Redmond, National Institutes of Health [NIH]),
and nuclear stain DAPI (1:10,000; Invitrogen). Secondary anti-
bodies used at 1:1,000 dilutions were Alexa Fluor 488-goat anti-
mouse IgG2A, Alexa Fluor 546-goat anti-rabbit immunoglobulin
G (IgG) (H+L), Alexa Fluor 488-goat anti-mouse IgG1, and Alexa
Fluor 546-goat anti-mouse IgG (H+L) (Invitrogen). Transwell
membranes were fixed with ice-cold 4% FA solution for 15 min
and then blocked and permeabilized with a solution containing
0.1% saponin, 5% normal goat serum, and 1% bovine serum
albumin in phosphate-buffered saline. Controls included incuba-
tions of secondary antibodies in the absence of primary antibodies
and block solutions in the absence of primary/secondary anti-
bodies. Fluorescent images were collected using a Leica TCS SP5
confocal microscope.
Paraffin Sections.
Some paraffin sections obtained from implant regions were pro-
cessed for immunocytochemistry against pan-cytokeratin (1:100;
catalog number ab11213, Abcam), ezrin (1:50; CST), MCT-1
(1:50; LifeSpan Biosciences), Ki67 (1:50; Sigma), phosphohistone
H3 (1:50; Millipore), caspase-3 (1:50, Promega), and human-
specific antibody SC121 (1:50; Stem Cells) to verify the presence
of human RPE cells on the subretinally implanted cell carriers.
Pan-cytokeratin was visualized with the Biotin-ExtrAvidin-AEC
chromogen system. All other primary antibodies were visualized
using Alexa Fluor secondary antibodies as mentioned above.
SUPPLEMENTAL INFORMATION
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